Cost-effectiveness of the adjuvanted respiratory syncytial virus prefusion F protein (RSVPreF3) vaccine in Japanese adults aged 50–59 years at increased risk of severe RSV disease and those aged ≥60 years

RSV vaccination may provide substantial health benefits and be a cost-effective intervention to reduce RSV burden in adults in Japan.

Authors

J Simons (ORCID: https://orcid.org/0000-0001-6656-4472)
Frederik Verelst (ORCID: https://orcid.org/0000-0001-8399-743X)
J. Christopher Graham (ORCID: https://orcid.org/0000-0002-9676-2717)
Eleftherios Zarkadoulas (ORCID: https://orcid.org/0009-0003-6940-6367)
MEI GRACE
Y. Ho
Daisuke Kurai
Kentaro Tajima

Institutions

Kyorin University (JP)
RTI Health Solutions (US)

Publication Details

Journal: Expert Review of Vaccines
Published: 2026-02-04
DOI: https://doi.org/10.1080/14760584.2026.2626921
Primary Topic: Respiratory viral infections research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cost-effectiveness of the adjuvanted respiratory syncytial virus prefusion F protein (RSVPreF3) vaccine in Japanese adults aged 50–59 years at increased risk of severe RSV disease and those aged ≥60 years

J Simons, Frederik Verelst, J. Christopher Graham, Eleftherios Zarkadoulas et al.

Feb 4, 2026

Expert Review of Vaccines

Respiratory viral infections research

article

Cost-effectiveness of the adjuvanted respiratory syncytial virus prefusion F protein (RSVPreF3) vaccine in Japanese adults aged 50–59 years at increased risk of severe RSV disease and those aged ≥60 years

J Simons, Frederik Verelst, J. Christopher Graham, Eleftherios Zarkadoulas, MEI GRACE, Y. Ho, Daisuke Kurai, Kentaro Tajima

February 4, 2026article en

Abstract

RSV vaccination may provide substantial health benefits and be a cost-effective intervention to reduce RSV burden in adults in Japan.

Expert Review of VaccinesVol. 25(1)

Kyorin University (JP), RTI Health Solutions (US)

Good health and well-being

Openalex Percentile: Top 65%

Respiratory viral infections research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.